使用小型RNA结合分子进行HIV-1转录抑制
Pooja Khatkar1, Gifty Mensah1, Shangbo Ning2
1Laboratory of Molecular Virology, School of Systems Biology, George Mason University, Manassas, VA 20110, USA.
Pharmaceuticals (Basel, Switzerland)
|January 23, 2024
概括
发现了新的HIV-1转录抑制剂,其向的是Tat-TAR相互作用. 这些分子在减少病毒蛋白表达和补充现有治疗方法来对抗艾滋病毒方面表现有前途.
科学领域:
- 病毒学 病毒学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 艾滋病毒-1 交换激活蛋白 Tat 结合了交换激活反应元素 (TAR) RNA 来驱动病毒转录.
- 针对Tat-TAR相互作用是开发新型HIV-1抗病毒疗法的关键策略.
- 目前的治疗方法没有专门抑制HIV-1转录,突出显示了治疗差距.
研究的目的:
- 识别和描述抑制HIV-1转录的新型小分子.
- 研究这些抑制剂对Tat-TAR-P-TEFb复合体和转录因子的作用机制.
- 在相关细胞模型中评估潜在候选药物的疗效和安全性.
主要方法:
- 通过查识别候选抑制剂.
- 分子对接和模拟以分析小分子与TAR RNA和P-TEFb的结合动态.
- 用于实验验证的生物化RNA拉回试验.
- 评估对转录因子的影响,如SWI/SNF复合体.
- 在HIV-1感染的骨髓细胞和T细胞中对病毒转录和蛋白质表达的评估.
主要成果:
- 确定了几种候选分子,可以抑制HIV-1转录在髓状细胞和T细胞中,没有明显的毒性.
- 两种分子显著抑制了病毒蛋白表达.
- 分子模拟显示了与TAR RNA和P-TEFb的结合相互作用,其中一些候选物诱导了TAR RNA循环中的结构变化.
- 最好的候选者在初级HIV-1感染细胞中实现了病毒转录的实质性抑制.
结论:
- 针对HIV-1转录的新型小分子已被确定,提供了一种新的治疗途径.
- 这些抑制剂有潜力补充当前的联合抗逆转录病毒疗法 (cART) 并解决未满足的需求.
- 针对TAR RNA循环和Tat结合部位对于开发有效的HIV-1转录抑制剂至关重要.
相关概念视频
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Types of RNA
5.8K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
5.8K
Eukaryotic Transcription Inhibitors
9.8K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.8K
Small interfering RNAs (siRNA)
3.5K
3.5K


